Introduction
============

Metastatic pulmonary calcification is a process performed in normal lung tissue with chronic renal disease. The patient was treated with immunosuppressive drugs following renal transplantation. The ground-glass opacities and nodular lesions, which are observed by a chest computed tomography (CT) scan may be signs of certain diseases, including cytomegalovirus pneumonia or pneumocystis carinii pneumonia. Cavity lesions with diffuse metastatic pulmonary calcification are rarely reported worldwide. In the present study, a case of metastatic pulmonary calcification following renal transplantation was reported in a patient whose CT scan of the chest revealed ground-glass opacities in bilateral lungs and cavity lesions in the upper right lung. Although aspergillus infection may be considered by chest CT, metastatic pulmonary calcification must not be ignored in clinical diagnosis.

Case report
===========

A 42-year-old man with renal failure received hemodialysis between November 2007 and 2008, prior to transplantation. The patient received renal transplantation in 2009. His maintenance immunotherapy consisted of mycophenolate (two capsules, twice/day); tacrolimus, (two capsules, twice/day) and methylprednisolone (40 mg daily). The patient improved following the treatment and was subsequently treated with methylprednisolone (4 mg/day). Lower extremity deep vein thrombosis was diagnosed by ultrasound in 2011 and the patient was treated with warfarin. On December 2012, the patient coughed white sputum and exhibited a fever at 39.6°C. A CT scan of the chest revealed ground-glass opacities in bilateral lungs and nodular lesions in the right upper lobe ([Fig. 1A](#f1-mco-0-0-723){ref-type="fig"}). The patient was treated with voriconazole (400 mg/day), ceftriaxone sodium (1 g/day) and moxifloxacin (0.4 g/day).

In May 2013, the patient was readmitted for a fever, with blood in the sputum. All vital signs were stable. The entire body skin was slightly red with a scattered rash. Normal vesicular sounds were heard on auscultation without rales. Laboratory findings were as follows: Hemoglobin, 167 g/l; white blood cell (WBC) count, 16.00×10^9^ cells/l; percentage of neutrophils, 0.859; C-reactive protein, 16.2 mg/l (normal range, \<5 mg/l); procalcitonin, 0.85 ng/ml (normal range, \<0.5 ng/ml); calcium, 2.41 mmol/l (normal range, 2.2--2.6 mmol/l); intact parathyroid hormone, 77.4 pg/ml (normal range, 15--65 pg/ml). A CT scan of the chest revealed diffuse ground-glass opacities in bilateral lungs and cavity lesions within a nodule in the right upper lobe. The ground-glass opacities changed more than previously ([Fig. 1B](#f1-mco-0-0-723){ref-type="fig"}). The result of a lung biopsy in the right upper lobe demonstrated excessive thickening of the alveolar septa, alveolar epithelial hyperplasia, infiltration of inflammatory cells, multinucleated giant cells and calcification in the right lung tissue. Fiber polypoid tissues were observed in the alveolar space ([Fig. 2](#f2-mco-0-0-723){ref-type="fig"}). Immunohistochemical staining revealed the expression of cluster of differentiation (CD)68 (tissue cells positive), transcriptional intermediary factor-1 (epithelium positive), cytokeratin (epithelium positive). The result of staining with fiber polypoid tissues obtained from the lungs revealed negative acid fast staining and negative for Periodic Acid-Schiff stain. No fungus or tubercle bacillus was observed by lung biopsy, and a lung tissue culture was negative.

According to clinical manifestation, medical history and a chest CT scan, aspergillus infection was initially considered in the patient. However, sustained treatment of voriconazole had little effect on the patient. Following a lung biopsy and sputum culture, pulmonary metastatic calcification was finally diagnosed in the patient. Anti-infective therapy was continued during his admission. The patient continued to take mycophenolate mofetil (250 mg 1/day) and methylprednisolone (4 mg 1/day) until he was discharged. In August 2013, the imaging of pulmonary infection on CT scan of the chest was improved ([Fig. 1C](#f1-mco-0-0-723){ref-type="fig"}). The infection parameters and calcium-phosphate product were stable. The patient exhibited a significant clinical improvement and was discharged. The patient was in good clinical condition during the follow-up. He returned to our outpatient department for examinations every 4 months. Comparing new chest CT imaging with the images following the initial admission revealed that the lesions did not deteriorate.

Discussion
==========

The present study searched previous cases of metastatic pulmonary calcification and eliminated those, which were irrelevant ([@b1-mco-0-0-723]--[@b12-mco-0-0-723]). The majority of the patients exhibited hypercalcemia and suffered from renal failure. Radiologically, metastatic pulmonary calcification predominantly appeared as diffuse small nodules with an unclear border, whose size ranged in diameter between 2 and 11 mm. The majority of nodules were discovered in the upper lung area. The majority of patients survived during the follow-up period.

Metastatic pulmonary calcification is a complication characterized by calcium salt deposition. It belongs to visceral calcification ([@b4-mco-0-0-723]) and may develop silently over years, and is often detected accidently. The pathogenesis is unclear; however, it is associated with calcium, phosphate, hemodialysis, hyperparathyroidism, renal failure, osteodystrophy, anticoagulants hypervitaminosis D and malignant tumor ([@b13-mco-0-0-723]--[@b16-mco-0-0-723]). Metastatic calcification may occur when calcium-phosphate products exceed 40 mg/dl^2^ ([@b17-mco-0-0-723],[@b18-mco-0-0-723]). In autopsy studies, metastatic pulmonary calcification is observed in 60--80 percent of long-term hemodialysis patients, although it is rarely recognized during life ([@b1-mco-0-0-723]). Calcium and phosphate were generally normal in the current patient during his admission. Long-term hemodialysis may lead to disorders of calcium and phosphate, which cause parathyroid hyperplasia. Additionally, parathormone must be secreted by it in order to balance electrolyte concentrations. It is difficult for calcium to be excreted with the urine in a patient with renal failure, and the calcium is deposited in the tissues. Low calcium in the plasma stimulates parathormone, which leads to increasing bone resorption. In addition, excessive secretion of parathormone is also caused by hyperparathyroidism ([@b14-mco-0-0-723]). In the previous studies, the majority of the patients are associated with excessive secretion of parathormone, including renal failure and hyperparathyroidism ([@b1-mco-0-0-723]--[@b12-mco-0-0-723]). In the present case, lower extremity deep vein thrombosis was diagnosed by ultrasound in 2011 and the patient was treated with warfarin. Anticoagulants, particularly warfarin, can inhibit carboxylation of coagulation factors in the liver and peripheral carboxylation of matrix Gla protein, which results in a lack of vitamin K^1^ and K^2^ ([@b8-mco-0-0-723]). Metastatic calcification may appear by this way. Certain malignant tumor types, particularly leukemia and multiple myeloma, can damage bone tissue, which releases calcium from the bone, contributing to hypercalcemia ([@b5-mco-0-0-723],[@b7-mco-0-0-723],[@b12-mco-0-0-723]).

A conventional chest radiograph seldom identifies calcification whose nodular opacities measure 2--12 mm in diameter ([@b3-mco-0-0-723]). However, high-resolution computer tomography (HRCT) scanning and 99mtechnetium-methylene diphosphate (99mTc-MDP) bone scintigraphy are sensitive and specific ([@b19-mco-0-0-723]). A CT scan of the chest following the patient being discharged home demonstrated that calcification exists in the tissue for a long duration. It is difficult for calcification to be absorbed completely when large numbers of calcium salts deposit in the tissue. In the previous cases, a chest CT scan of metastatic pulmonary calcification reveals diffuse, fluffy and ground-glass nodular opacities in the upper zones ([@b1-mco-0-0-723]--[@b12-mco-0-0-723]). The predilection of metastatic pulmonary calcification for the upper lung area may be due to the high ventilation/perfusion (V/Q) ratio in this region, creating low carbon dioxide and high oxygen levels ([@b8-mco-0-0-723]). The V/Q ratio is high (\~3.3) in the upper region and gradually reduces from apex to base (\~0.63) in the lung. The high V/Q ratio results in decreased PaCO^2^ and increased pH. Calcium salt deposition is associated with the relative alkalinity. As a result, metastatic pulmonary calcification usually occurs in the upper zones. Lung biopsy with pathological examination is the most accurate diagnosis for metastatic pulmonary calcification compared with HRCT or ^99m^ Tc-MDP, although they are sensitive. However, lung biopsy is more invasive compared with other examinations. Small quantities of calcification have little influence on patients, resulting in the probability of refusing a lung biopsy.

No appropriate treatment can be applied to metastatic pulmonary calcification. In previous cases, decreasing calcium in plasma was commonly used to treat calcification, including thyroparathyroidectomy and renal transplantation ([@b1-mco-0-0-723]--[@b12-mco-0-0-723]). In the present case, the calcium level was normal, and the patient underwent long-term immunotherapy. Aspergillus infection was as empirical diagnosis, according to the CT scan of the chest ([Fig. 1A](#f1-mco-0-0-723){ref-type="fig"}). Following biopsy in the right lung, metastatic pulmonary calcification was finally diagnosed. Notably, pulmonary function test results are usually normal in the early stage of calcification. With regard to metastatic pulmonary calcification, no abnormal symptoms can be observed in the early stage of small foci of calcification. The patient exhibited no symptoms and was not influenced by calcification. As the disease progresses, restrictive lung changes may develop with a decrease in vital capacity, diffusion capacity and hypoxemia. Prognosis depends on clinical conditions in patients. In addition, patients succumb to other diseases instead of calcification.

The present report expands metastatic pulmonary calcification with cavity lesions in the right upper lobe and in a patient following renal transplantation. The clinical symptoms of metastatic pulmonary calcification are not obvious. According to medical history and a CT scan of the chest ([Fig. 1A](#f1-mco-0-0-723){ref-type="fig"}), aspergillus infection was taken into consideration. However, lung biopsy and sputum culture demonstrated metastatic pulmonary calcification. Despite its rarity, metastatic pulmonary calcification must not be forgotten in clinical diagnosis when cavity lesions in the lungs are discovered in a patient. Regulating the balance of blood ions and improving immunity may reduce the incidence of calcification.

![A computed tomography scan of the chest revealed (A) ground-glass opacities in bilateral lungs and a nodule exhibiting the halo sign in right upper lobe (10 December 2012), (B) diffuse ground-glass opacities in bilateral lungs and cavity lesions within a mass exhibiting the halo sign in right upper lobe (30 May 2013), and (C) diffuse ground-glass opacities in bilateral lungs and cavity lesions with thin cavity wall in right upper lobe. (6 August 2013).](mco-04-03-0409-g00){#f1-mco-0-0-723}

![Pathology results in alveolar space. (A) Excessive thickening of the alveolar septa was observed. (B) Alveolar epithelial hyperplasia, infiltration of inflammatory cell and multinucleated giant cells were discovered in the tissue. (C) Calcification and ossification was observed. (D) Fiber polypoid tissues were observed in the alveolar space.](mco-04-03-0409-g01){#f2-mco-0-0-723}
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